| Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients NM Kuderer, DC Dale, J Crawford, LE Cosler, GH Lyman Cancer 106 (10), 2258-2266, 2006 | 1447 | 2006 |
| Risk and timing of neutropenic events in adult cancer patients receiving chemotherapy: the results of a prospective nationwide study of oncology practice J Crawford, DC Dale, NM Kuderer, E Culakova, MS Poniewierski, D Wolff, ... Journal of the National Comprehensive Cancer Network 6 (2), 109-118, 2008 | 295 | 2008 |
| Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapy GH Lyman, NM Kuderer, J Crawford, DA Wolff, E Culakova, ... Cancer 117 (9), 1917-1927, 2011 | 293 | 2011 |
| The impact of the granulocyte colony-stimulating factor on chemotherapy dose intensity and cancer survival: a systematic review and meta-analysis of randomized controlled trials GH Lyman, DC Dale, E Culakova, MS Poniewierski, DA Wolff, ... Annals of oncology 24 (10), 2475-2484, 2013 | 223 | 2013 |
| Acute myeloid leukemia or myelodysplastic syndrome in randomized controlled clinical trials of cancer chemotherapy with granulocyte colony-stimulating factor: a systematic review GH Lyman, DC Dale, DA Wolff, E Culakova, MS Poniewierski, ... Journal of Clinical Oncology 28 (17), 2914-2924, 2010 | 223 | 2010 |
| Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer GH Lyman, E Culakova, MS Poniewierski, NM Kuderer Thrombosis research 164, S112-S118, 2018 | 182 | 2018 |
| Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens JJ Griggs, E Culakova, MES Sorbero, MS Poniewierski, DA Wolff, ... Journal of clinical oncology 25 (18), 2522-2527, 2007 | 169 | 2007 |
| Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy JJ Griggs, E Culakova, MES Sorbero, M Van Ryn, MS Poniewierski, ... Journal of clinical oncology 25 (3), 277-284, 2007 | 145 | 2007 |
| Dose intensity and hematologic toxicity in older cancer patients receiving systemic chemotherapy M Shayne, E Culakova, MS Poniewierski, D Wolff, DC Dale, J Crawford, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2007 | 144 | 2007 |
| Patterns of chemotherapy‐associated toxicity and supportive care in US oncology practice: a nationwide prospective cohort study E Culakova, R Thota, MS Poniewierski, NM Kuderer, AF Wogu, DC Dale, ... Cancer medicine 3 (2), 434-444, 2014 | 125 | 2014 |
| Predictors of reduced relative dose intensity and its relationship to mortality in women receiving multi-agent chemotherapy for epithelial ovarian cancer RK Hanna, MS Poniewierski, RA Laskey, MA Lopez, A Shafer, L Van Le, ... Gynecologic oncology 129 (1), 74-80, 2013 | 96 | 2013 |
| Predictors of venous thromboembolism and early mortality in lung cancer: results from a global prospective study (CANTARISK) NM Kuderer, MS Poniewierski, E Culakova, GH Lyman, AA Khorana, ... The oncologist 23 (2), 247-255, 2018 | 89 | 2018 |
| First Cycle Risk of Severe and Febrile Neutropenia in Cancer Patients Receiving Systemic Chemotherapy: Results from a Prospective Nationwide Study. J Crawford, DA Wolff, E Culakova, MS Poniewierski, C Selby, DC Dale, ... Blood, The Journal of the American Society of Hematology 104 (11), 2210-2210, 2004 | 53 | 2004 |
| Predictors of severe and febrile neutropenia during primary chemotherapy for ovarian cancer RA Laskey, MS Poniewierski, MA Lopez, RK Hanna, AA Secord, ... Gynecologic oncology 125 (3), 625-630, 2012 | 51 | 2012 |
| Variation in the cost of medications for the treatment of colorectal cancer D Wolff, MS Poniewierski, E Culakova, GH Lyman Am J Manag Care 14 (11), 717-725, 2008 | 49 | 2008 |
| Dose intensity and hematologic toxicity in older breast cancer patients receiving systemic chemotherapy M Shayne, E Culakova, D Wolff, MS Poniewierski, DC Dale, J Crawford, ... Cancer 115 (22), 5319-5328, 2009 | 47 | 2009 |
| Analysis of factors associated with in-hospital mortality in lung cancer chemotherapy patients with neutropenia J Cupp, E Culakova, MS Poniewierski, DC Dale, GH Lyman, J Crawford Clinical Lung Cancer 19 (2), e163-e169, 2018 | 40 | 2018 |
| Risk factors for in-hospital mortality and prolonged length of stay in older patients with solid tumor malignancies M Shayne, E Culakova, MS Poniewierski, DC Dale, J Crawford, AF Wogu, ... Journal of geriatric oncology 4 (4), 310-318, 2013 | 36 | 2013 |
| Risk assessment scores for cancer-associated venous thromboembolic disease D Angelini, AA Khorana Seminars in thrombosis and hemostasis 43 (05), 469-478, 2017 | 35 | 2017 |
| Pharmacoeconomics of the myeloid growth factors: a critical and systematic review BR Hirsch, GH Lyman Pharmacoeconomics 30, 497-511, 2012 | 33 | 2012 |
